The National Health Service (NHS) approves a £1.65 million gene therapy for sickle cell disease in England, offering a potential cure with a 96.6% success rate. This newly approved treatment, exa-cel, provides a breakthrough solution for individuals suffering from severe sickle cell disease, particularly those eligible for a stem cell transplant but lacking a matched … Continue reading NHS Approves £1.65 Million Sickle Cell Treatment With 96.6% Success Rate